NCT01578473View on ClinicalTrials.gov

Testosterone Pellets Plus Vitamin D and E Versus Vitamin D and E Alone for the Treatment of Peyronie's Disease

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 23, 2013

Primary Completion Date

July 7, 2013

Study Completion Date

November 13, 2017

Conditions

Peyronie's Disease

Interventions

DRUG

Vitamin D2

oral softgel 2000 IU once daily 9 months

DRUG

Vitamin E

"oral softgels 400 IU and 200 IU 1 softgel of 400 IU daily~1 softgel of 200 IU daily 9 months"

DRUG

Testosterone Pellets

subcutaneous implantation pellets 75 mg based on testosterone levels from resulting bloodwork 9 months

Trial Locations (1)

02467

Men's Health Boston, Chestnut Hill

All Listed Sponsors

lead

Men's Health Boston

OTHER

NCT01578473 - Testosterone Pellets Plus Vitamin D and E Versus Vitamin D and E Alone for the Treatment of Peyronie's Disease | Biotech Hunter | Biotech Hunter